European Society of Cardiology (ESC) Annual Congress Report From Barcelona 2017

  • Satoh Kimio
    Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
  • Takahashi Jun
    Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
  • Matsumoto Yasuharu
    Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
  • Tatebe Shunsuke
    Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
  • Aoki Tatsuo
    Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
  • Kikuchi Yoku
    Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
  • Hao Kiyotaka
    Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
  • Ohyama Kazuma
    Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
  • Nogi Masamichi
    Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
  • Suda Akira
    Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
  • Kasahara Shintaro
    Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
  • Sato Koichi
    Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
  • Ichijo Sadamitsu
    Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
  • Shimokawa Hiroaki
    Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine

Bibliographic Information

Other Title
  • 2017 ESC REPORT : European Society of Cardiology (ESC) Annual Congress Report From Barcelona 2017

Search this article

Description

<p>From August 26th to 30th, the 2017 Annual Congress of the European Society of Cardiology (ESC 2017) was held in Barcelona, Spain. Despite the terrorism tradegy just before the ESC congress, the congress attracted many medical professionals from all over the world to discuss the recent topics in cardiovascular medicine in more than 500 sessions, including COMPASS (Cardiovascular OutcoMes for People using Anticoagulation StrategieS Trial), CANTOS (Canakinumab Anti-Inflammatory Thrombosis Outcomes Study), and ORION (which assessed the effect of a novel siRNA inhibitor to PCSK9 on reductions in low-density lipoprotein cholesterol). Japanese cardiologists and the Japanese Circulation Society greatly contributed to the congress. This report briefly introduces some late-breaking registry results, late-breaking clinical trials, and ESC Guidelines from the ESC 2017 Congress.</p>

Journal

  • Circulation Journal

    Circulation Journal 81 (12), 1758-1763, 2017

    The Japanese Circulation Society

Citations (2)*help

See more

References(17)*help

See more

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top